Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joonhyuk Cho

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Plos One|January 26, 2024
How does news affect biopharma stock prices?: An event studyJoonhyuk Cho, Manish Singh, Andrew W Lo
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|October 26, 2022
Incorporating patient preferences and burden-of-disease in evaluating ALS drug candidate AMX0035: a Bayesian decision analysis perspectiveQingyang Xu, Joonhyuk Cho, Zied Ben Chaouch, et al.
Contemporary Clinical Trials Communications|April 18, 2025
Predicting clinical trial duration via statistical and machine learning modelsJoonhyuk Cho, Qingyang Xu, Chi Heem Wong, et al.
PLOS Global Public Health|June 16, 2026
The Health of Nations Fund: Financing global drug developmentJoonhyuk Cho, Manish Singh, Chaoyi Zhao, et al.
Drug Discovery Today|June 16, 2026
Estimating the global inventory of deprioritized clinical-stage drug development programs: Toward a market for shelved assetsAnnette Bakker, Tanisha Carino, Joonhyuk Cho, et al.
Plos One|July 2, 2025
Financing drug development via adaptive platform trialsJoonhyuk Cho, Eugene Sorets, Shomesh Chaudhuri, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Plos One|January 26, 2024
How does news affect biopharma stock prices?: An event studyJoonhyuk Cho, Manish Singh, Andrew W Lo
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|October 26, 2022
Incorporating patient preferences and burden-of-disease in evaluating ALS drug candidate AMX0035: a Bayesian decision analysis perspectiveQingyang Xu, Joonhyuk Cho, Zied Ben Chaouch, et al.
Contemporary Clinical Trials Communications|April 18, 2025
Predicting clinical trial duration via statistical and machine learning modelsJoonhyuk Cho, Qingyang Xu, Chi Heem Wong, et al.
PLOS Global Public Health|June 16, 2026
The Health of Nations Fund: Financing global drug developmentJoonhyuk Cho, Manish Singh, Chaoyi Zhao, et al.
Drug Discovery Today|June 16, 2026
Estimating the global inventory of deprioritized clinical-stage drug development programs: Toward a market for shelved assetsAnnette Bakker, Tanisha Carino, Joonhyuk Cho, et al.
Plos One|July 2, 2025
Financing drug development via adaptive platform trialsJoonhyuk Cho, Eugene Sorets, Shomesh Chaudhuri, et al.
Pageof 1